Dr. Gillett & James O'Hara discuss the FDA ruling on MDMA.

00:00 Intro

01:10 FDA's decision on MDMA therapy is pending, with possibilities ranging from approval.

06:00 MDMA affects various hormones post-consumption, including serotonin and cortisol, potentially impacting mood and physiology.

09:30 MDMA trials for PTSD

14:55 Concerns over MDMA trials

21:32 FDA critiques MDMA therapy training protocols for therapists to prevent abuse.

24:33 MDMA is considered safer compared to benzodiazepines in certain respects.

27:33 Balancing drug accessibility and safety through regulatory measures is crucial to advancing scientific research and ensuring public health.

29:30 Outro

Studies/References:

► https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/31734398/

► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205851/

► https://www.nature.com/articles/s41591-023-02565-4

► https://abcnews.go.com/Health/fda-advisers-recommending-mdma-treatment-ptsd/story?id=110808948

For High-Quality Labs:

► https://gilletthealth.com/order-lab-panels/

For information on the Gillett Health clinic, lab panels, and health coaching:

► https://GillettHealth.com

Follow Gillett Health for more content from James and Kyle

► https://instagram.com/gilletthealth

► https://www.tiktok.com/@gilletthealth

► https://twitter.com/gilletthealth

► https://www.facebook.com/gilletthealth

Follow Kyle Gillett, MD

► https://instagram.com/kylegillettmd

Follow James O’Hara, NP

► https://Instagram.com/jamesoharanp

For 10% off Gorilla Mind products including SIGMA: Use code “GH10”

► https://gorillamind.com/

For discounts on high-quality supplements

►https://www.thorne.com/u/GillettHealth

#ptsd #fda #podcast